MRI-leukoaraiosis thresholds and the phenotypic expression of dementia
Department of Clinical and Health Psychology, University of Florida, Gainesville, USA. Neurology
(Impact Factor: 8.29).
07/2012; 79(8):734-40. DOI: 10.1212/WNL.0b013e3182661ef6
To examine the concept of leukoaraiosis thresholds on working memory, visuoconstruction, memory, and language in dementia.
A consecutive series of 83 individuals with insidious onset/progressive dementia clinically diagnosed with Alzheimer disease (AD) or small vessel vascular dementia (VaD) completed neuropsychological measures assessing working memory, visuoconstruction, episodic memory, and language. A clinical MRI scan was used to quantify leukoaraiosis, total white matter, hippocampus, lacune, and intracranial volume. We performed analyses to detect the lowest level of leukoaraiosis associated with impairment on the neuropsychological measures.
Leukoaraiosis ranged from 0.63% to 23.74% of participants' white matter. Leukoaraiosis explained a significant amount of variance in working memory performance when it involved 3% or more of the white matter with curve estimations showing the relationship to be nonlinear in nature. Greater leukoaraiosis (13%) was implicated for impairment in visuoconstruction. Relationships between leukoaraiosis, episodic memory, and language measures were linear or flat.
Leukoaraiosis involves specific threshold points for working memory and visuoconstructional tests in AD/VaD spectrum dementia. These data underscore the need to better understand the threshold at which leukoaraiosis affects and alters the phenotypic expression in insidious onset dementia syndromes.
Available from: PubMed Central
- "The degree of WM integrity inferred directly or indirectly has been the focus of numerous studies in aging and dementia. Given improvements in image quantification the degree of WM lesion burden in the elderly individual is associated with increased levels of dementia and in those where changes in WM are quantified over time, the degree of WM burden predicts transition from mild cognitive impairment (MCI) to Alzheimer's disease (Carlson et al., 2008; Price et al., 2012; Silbert et al., 2012). Silbert et al. (2012), in a longitudinal, prospective neuroimaging study that measured WM volume as well as CSF, identified WM changes 10 years prior to MCI onset. "
[Show abstract] [Hide abstract]
ABSTRACT: Depending on severity, traumatic brain injury (TBI) induces immediate neuropathological effects that in the mildest form may be transient but as severity increases results in neural damage and degeneration. The first phase of neural degeneration is explainable by the primary acute and secondary neuropathological effects initiated by the injury; however, neuroimaging studies demonstrate a prolonged period of pathological changes that progressively occur even during the chronic phase. This review examines how neuroimaging may be used in TBI to understand (1) the dynamic changes that occur in brain development relevant to understanding the effects of TBI and how these relate to developmental stage when the brain is injured, (2) how TBI interferes with age-typical brain development and the effects of aging thereafter, and (3) how TBI results in greater frontotemporolimbic damage, results in cerebral atrophy, and is more disruptive to white matter neural connectivity. Neuroimaging quantification in TBI demonstrates degenerative effects from brain injury over time. An adverse synergistic influence of TBI with aging may predispose the brain injured individual for the development of neuropsychiatric and neurodegenerative disorders long after surviving the brain injury.
[Show abstract] [Hide abstract]
Health comorbidities, particularly cardiovascular factors, are well known to pose risks for cognitive decline in older adults. This study examined the prevalence and contribution of comorbidities on cognitive performance in a large cohort of Parkinson patients.
Data on 1948 PD patients were obtained from the National Parkinson Foundation Quality Improvement Initiative (NPF-QII) registry, a multi-site initiative from NPF Centers of Excellence. Available comorbidity data included six common conditions (heart/circulation problems, diabetes, arthritis, cancer, respiratory disease, and other neurologic disease) that were clinician-rated for presence and severity. Available cognitive measures included semantic fluency and a 5-word recall memory task. The unique effects of comorbidities on cognition were analyzed (multiple hierarchical regression) controlling for demographic, PD disease severity (duration, Hoehn-Yahr), and medication status.
The two most reported comorbidities were arthritis (46.6%) and heart/circulation problems (36.3%), with diabetes affecting 9% of the sample. Severity of heart/circulation problems independently contributed to worse delayed recall performance (p = 0.03). A trend emerged for more severe diabetes as contributing to worse semantic fluency scores (p = 0.06).
This study with a large cohort of PD patients provides evidence for a small detrimental influence of specific health comorbidities, particularly heart/circulatory and diabetes, on general measures of cognition. This effect is present, above and beyond the influences of basic demographic information (age), duration and staging of PD, and medication status. Future studies involving more refined cognitive indices and direct assessment of comorbidities are warranted.
[Show abstract] [Hide abstract]
ABSTRACT: Dementia researchers are struggling to clarify the clinical relevance of a brain imaging finding that is common among cognitively healthy elderly individuals.(1) It is associated with increased risk of clinical dementia,(2) but the time course of this progression is not fully understood. It may begin to occur as early as the fifth or sixth decade of life(3) and may persist for many years before clinical symptoms become apparent. There are good reasons to believe that the neurobiological events giving rise to this imaging finding are deleterious. However, it is currently not known whether prevention or reversal of these events is sufficient to prevent a cascade of brain injury processes that eventually culminates in clinical dementia.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.